SCHEMBL21583802

SCHEMBL21583802

COC(=O)CNC(=O)c1cc(C)on1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
MAPT P10636 2/20 0.54
PSMB11 A5LHX3 1/20 0.52
PSMA7 O14818 1/20 0.52
PSMB1 P20618 1/20 0.52
PSMA1 P25786 1/20 0.52
PSMA2 P25787 1/20 0.52
PSMA3 P25788 1/20 0.52
PSMA4 P25789 1/20 0.52
PSMB8 P28062 1/20 0.52
PSMB9 P28065 1/20 0.52
PSMA5 P28066 1/20 0.52
PSMB4 P28070 1/20 0.52
PSMB6 P28072 1/20 0.52
PSMB5 P28074 1/20 0.52
PSMB10 P40306 1/20 0.52
PSMB3 P49720 1/20 0.52
PSMB2 P49721 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18759302 0.85 CYP2C19 (0.65) CYP2C19CYP1A2CYP2D6MAPTPSMB11
SCHEMBL10207505 0.83 CYP2C19 (0.59) CYP2C19CYP1A2CYP2D6MAPTPSMB11
SCHEMBL8336741 0.82 CYP2C19 (0.57) CYP2C19CYP1A2CYP2D6MAPTPSMB11
SCHEMBL1021659 0.82 CYP2C19 (0.57) CYP2C19CYP1A2CYP2D6MAPTNPC1
SCHEMBL18759229 0.80 CYP1A2 (0.66) CYP2C19CYP1A2CYP2D6MAPTNPC1
SCHEMBL13631419 0.80 CYP2C19 (0.69) CYP2C19CYP1A2CYP2D6MAPTPSMB11
SCHEMBL22757712 0.79 CYP2C19 (0.58) CYP2C19CYP1A2CYP2D6MAPTPSMB11
SCHEMBL13444578 0.79 PSMB11 (0.57) CYP2C19CYP1A2CYP2D6MAPTPSMB11
SCHEMBL10202740 0.79 CYP2C19 (0.57) CYP2C19CYP1A2CYP2D6MAPTPSMB11
SCHEMBL16215617 0.78 CYP2C19 (0.60) CYP2C19CYP1A2CYP2D6MAPTPSMB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542283-B2 Synthesis of peptide borate ester compound and use thereof JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) 2023-01-03 US disclosed
US-11542283-B2 Synthesis of peptide borate ester compound and use thereof JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) 2023-01-03 US disclosed
US-20210214377-A1 SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) 2021-07-15 US disclosed
US-20210214377-A1 SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) 2021-07-15 US disclosed
EP-3805237-A1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CN) 2021-04-14 EP disclosed
EP-3805237-A1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CN) 2021-04-14 EP disclosed
WO-2019228299-A1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND 江苏正大丰海制药有限公司 (CN) 2019-12-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214377-A1 SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF SEM1, VIP, PSMB11 CYP2C19 2389/4885CYP1A2 4739/4885CYP2D6 3629/4885
US-11542283-B2 Synthesis of peptide borate ester compound and use thereof SEM1, VIP, PSMB11 CYP2C19 2389/4885CYP1A2 4739/4885CYP2D6 3629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.